Today, August 16, marks two years since the signing of the #InflationReductionAct (IRA), passed on August 16, 2022. Since being signed into law, the #IRA has continued to implement significant changes to #healthcare as we know it, and we only anticipate more to come. Every step of the way, the ADVI Health team monitors our clients' most recent developments and prepares them for what is next. Get in touch with our #ADVIExperts: https://lnkd.in/eMY82JXm
ADVI Health
Business Consulting and Services
Washington, DC 5,517 followers
We solve complicated problems in healthcare with data-informed commercialization, market access, and policy expertise.
About us
ADVI is a commercial strategy and business development consulting firm that thrives on solving complicated problems in an evolving healthcare system. We are a specialized team of operators, policymakers, and clinicians with extensive experience delivering pragmatic results-oriented approach. We deliver a comprehensive perspective by integrating business, policy, and science to find creative solutions through data, learned insight and compelling strategy to help make decisions across all segments of healthcare. The firm represents a sophisticated client base of Fortune 500 life sciences and health care service companies as well as venture and private equity backed companies in diagnostics, digital health, health IT and health care services. The firm is at the forefront of health care delivery transformation, payment reform, public and private payer coverage, and healthcare merger and acquisition deal flow, within the US and abroad.
- Website
-
http://www.advi.com
External link for ADVI Health
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Headquarters
- Washington, DC
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Reimbursement, Market Access, Commercialization, and Healthcare Policy
Locations
-
Primary
1050 K St NW, Suite 340
Washington, DC 20001, US
Employees at ADVI Health
-
Kip Piper, MA, FACHE
Medicaid Advisor | Strategy, Policy, and Business | Consultant
-
Marc Samuels
Founder. CEO. Board Member. Writer. Speaker. Talks about #cellandgenetherapy, #raredisease, #healthpolicy, #cms
-
Ben Shand
Head of Business Development at ADVI Health
-
Michael Beebe
Partner, Co-founder ADVI
Updates
-
👏 #ADVIApplause: ADVI Health's employee recognition program uses the concept of applause to acknowledge and celebrate outstanding accomplishments, contributions, teamwork, and commitment to ADVI's core values: Act with Integrity, Strive for Excellence, Stay Curious, Make an Impact, Invest in our Community, and Have Fun. In July, ADVI's federal and state policy interns, Faith Heinaman and Suhanee Patel, were each recognized with the ADVI Applause award for the remarkable work that they have contributed throughout the summer. Representing ADVI's core values of #MakeAnImpact and #HaveFun, Faith and Suhanee became well-versed in evolving considerations for prescription drug affordability boards (PDABs), briefed top clients on complicated health policy topics, and notably added to the vibrant dynamic of the policy team! Please join us in celebrating and thanking Faith and Suhanee for their dedication and efforts to go above and beyond. If you are considering what is next for your career, learn more about joining #ADVIHealth: https://lnkd.in/ggyCHSgR
-
-
ADVI Health's newly-appointed chief financial officer, Christopher Wittwer, was recently recognized in the Kansas City Business Journal, featuring his experience, achievements, and role at ADVI. Read the full article to learn more about the Kansas native: https://lnkd.in/gRZ8jAJC
-
-
On July 16, the Centers for Medicare & Medicaid Services (CMS) released the final part two guidance on the Medicare Prescription Payment Plan (MPPP). This plan implements the #InflationReductionAct's maximum monthly cap on cost-sharing payments under Prescription Drug Plans and MA-PD plans. ADVI Health experts summarize this guidance in the latest #ADVIInstant*: https://lnkd.in/eqq2KtbU *This is a delayed release. ADVI Instant content is distributed in real-time for retainer clients.
-
-
What challenges have been present in cancer screenings, and why has their ability to provide accurate and beneficial results been questioned? In a recent release for his "Decoding Health Care" series, #ADVIExpert and senior advisor, Michael Kolodziej, MD, discusses the evolution of cancer screenings and the role they have played in mitigating unnecessary treatments and lives lost. Read more of Dr. Kolodziej's insights: https://lnkd.in/gagFKWB9
-
📢 ADVI Health welcomes Christopher Wittwer to the team as chief financial officer. In his role, Chris works with solution leaders and business development to maximize development and optimize sales, distilling financial modeling and analyses into actionable insights and translating data for audiences across ADVI. We are thrilled that Chris will contribute to ADVI's growth and mission with his 20+ years of experience in the industry. Read the full announcement: https://lnkd.in/e-Y7-EEp
-
With drugs targeted under the #InflationReductionAct (IRA), how can #lifesciences manufacturers prepare for negotiations with the Centers for Medicare & Medicaid Services (CMS)? ADVI Health's federal and state policy solution team supported a large life sciences manufacturer that was selected as one of the first ten products under the #IRA for negotiation, helping them anticipate CMS’ approach to negotiation, predict how CMS might weigh manufacturer evidence submission and real-world evidence, and develop strategies to strengthen its narrative and arguments to CMS to ensure that negotiated “maximum fair prices” (MFPs) accurately reflect the patient perspective and overall value of the client’s products. Read the full case study: https://lnkd.in/eF8qwrp3
Case Study: Strengthening Positioning for IRA Drug Price Negotiation | ADVI
https://advi.com
-
Our understanding of how targeting gene mutations impacts cancer care has exploded with the new developments of NGS panels. In the latest release of his "Decoding Health Care" series, #ADVIExpert and senior advisor, Michael Kolodziej, MD, analyzes approaches to precision medicine, and questions about it that still need to be answered: https://lnkd.in/gagFKWB9
-
-
On July 10, the Centers for Medicare & Medicaid Services (CMS) issued the 2025 Medicare Physician Fee Schedule (PFS) proposed rule and other revisions to payment policies on #Medicare Part B. This year's PFS includes a 2.80 percent rate decrease, along with proposed policies for the #InflationReductionAct (IRA) Prescription Drug Inflation Rebate Program. Read more in our latest #ADVIInstant*: https://lnkd.in/ec-PGD5S *This is a delayed release. ADVI Instant content is distributed in real-time for retainer clients.
ADVI Instant: CMS Releases 2025 Physician Fee Schedule and Proposed Rule | ADVI
https://www.advi.com
-
#ICYMI: Lindsay Bealor Greenleaf, ADVI Health's federal and state policy solution leader, spoke with POLITICO about the #healthcare perspective of vice president Kamala Harris' policies in light of her potential to be named as the Democratic nominee in this year's 2024 #PresidentialElection. Lindsay shares insight on how Harris' policies for implementing drug-related provisions to the #InflationReductionAct (IRA) could differ from the current administration's. Read the full article: https://lnkd.in/gU_KnnzG #2024Election #IRA
-